$-0.04 EPS Expected for Omnicell, Inc. (OMCL)

April 18, 2018 - By Richard Conner

Omnicell, Inc. (NASDAQ:OMCL) LogoInvestors sentiment increased to 1.12 in Q4 2017. Its up 0.10, from 1.02 in 2017Q3. It is positive, as 14 investors sold Omnicell, Inc. shares while 72 reduced holdings. 27 funds opened positions while 69 raised stakes. 37.38 million shares or 0.77% more from 37.10 million shares in 2017Q3 were reported.
Monroe Commercial Bank Trust Mi accumulated 33,934 shares or 0.4% of the stock. Eagle Asset Mngmt holds 0.36% or 1.37M shares. Moreover, Paradigm Capital Mgmt New York has 1.71% invested in Omnicell, Inc. (NASDAQ:OMCL) for 413,300 shares. Ameritas Investment Prtnrs reported 3,074 shares. Foundry Ltd has invested 0.08% in Omnicell, Inc. (NASDAQ:OMCL). Martingale Asset Mngmt Limited Partnership invested in 45,207 shares. Dubuque Natl Bank Trust Communication has invested 0.09% in Omnicell, Inc. (NASDAQ:OMCL). Needham Management Ltd Liability accumulated 13,000 shares or 0.17% of the stock. Brinker Cap has invested 0.01% in Omnicell, Inc. (NASDAQ:OMCL). Dimensional Fund Advsr Limited Partnership has 0.03% invested in Omnicell, Inc. (NASDAQ:OMCL). Oak Ridge Investments Lc reported 1.74% of its portfolio in Omnicell, Inc. (NASDAQ:OMCL). Zurcher Kantonalbank (Zurich Cantonalbank) reported 1,812 shares. Moreover, Diversified Trust has 0.01% invested in Omnicell, Inc. (NASDAQ:OMCL) for 4,300 shares. Waddell Reed invested in 0.01% or 130,097 shares. Principal Incorporated reported 513,069 shares.

Since December 15, 2017, it had 0 buys, and 4 selling transactions for $520,345 activity. $361,938 worth of Omnicell, Inc. (NASDAQ:OMCL) was sold by LIPPS RANDALL A. PETERSMEYER GARY S sold 575 shares worth $25,544.

Analysts expect Omnicell, Inc. (NASDAQ:OMCL) to report $-0.04 EPS on May, 3.They anticipate $0.25 EPS change or 86.21 % from last quarter’s $-0.29 EPS. After having $0.28 EPS previously, Omnicell, Inc.’s analysts see -114.29 % EPS growth. The stock decreased 1.44% or $0.65 during the last trading session, reaching $44.35. About 236,912 shares traded. Omnicell, Inc. (NASDAQ:OMCL) has risen 5.20% since April 18, 2017 and is uptrending. It has underperformed by 6.35% the S&P500.

Omnicell, Inc. (NASDAQ:OMCL) Ratings Coverage

Among 5 analysts covering Omnicell (NASDAQ:OMCL), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Omnicell had 11 analyst reports since October 19, 2017 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Buy” rating and $63.0 target in Thursday, February 1 report. The rating was maintained by Oppenheimer with “Buy” on Tuesday, December 5. The stock of Omnicell, Inc. (NASDAQ:OMCL) earned “Buy” rating by Oppenheimer on Monday, January 29. Craig Hallum maintained it with “Buy” rating and $62.0 target in Monday, October 30 report. As per Tuesday, December 5, the company rating was maintained by Cantor Fitzgerald. Cantor Fitzgerald maintained Omnicell, Inc. (NASDAQ:OMCL) on Thursday, October 26 with “Buy” rating. The stock has “Hold” rating by Craig Hallum on Friday, February 2. The rating was maintained by Piper Jaffray with “Hold” on Friday, October 27. The firm earned “Buy” rating on Thursday, October 19 by Oppenheimer. Oppenheimer maintained the shares of OMCL in report on Friday, October 27 with “Buy” rating.

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company has market cap of $1.72 billion. The firm operates through two divisions, Automation and Analytics, and Medication Adherence. It has a 83.68 P/E ratio. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems.

Omnicell, Inc. (NASDAQ:OMCL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.